Improving Patient Safety through Pharmacist- and Pharmacy Technician-Driven Medication Reconciliations at Transitions of Care

Size: px
Start display at page:

Download "Improving Patient Safety through Pharmacist- and Pharmacy Technician-Driven Medication Reconciliations at Transitions of Care"

Transcription

1 Improving Patient Safety through Pharmacist- and Pharmacy Technician-Driven Medication Reconciliations at Transitions of Care Julie H. McGinley, PharmD, MHS Southern Illinois University Edwardsville, School of Pharmacy

2 Disclosure and Conflict of Interest I, Julie H. McGinley declare no conflicts of interest, real or apparent, and no financial interests in any company, product, or service mentioned in this program, including grants, employment, gifts, stock holdings, and honoraria.

3 Pharmacist Objectives At the conclusion of this program, the pharmacist will be able to: 1. Explain why it is important to have pharmacists and/or pharmacy technicians involved in medication reconciliation (MR) at transitions of care (TOC). 2. Identify times when TOC MRs should occur. 3. Discuss strategies to implement a pharmacydriven MR program.

4 Technician Objectives At the conclusion of this program, the technician will be able to: 1. Identify high-risk medications which are more likely to lead to patient harm and may require a pharmacist s intervention. 2. Recognize directions for use (Sig codes) which require further clarification. 3. Describe the role of pharmacy technicians with regard to MR at TOC.

5 Pre-Test Question 1 1. Medication reconciliations at TOC are important because: a. The Joint Commission has designated inpatient medication reconciliation as a National Patient Safety Goal b. Errors such as omissions and duplications, dosing changes and new drug-drug interactions can significantly compromise patient safety c. Readmission rates and medication errors decline overall when medications are reconciled d. All of the above

6 Pre-Test Question 2 1. When should a TOC medication reconciliation occur? Choose all that apply: a. Upon emergency department admission b. Upon inpatient admission c. Upon transfer from one unit to another d. Upon transfer from one room to another within the same unit

7 Pre-Test Question 3 1. Which medication falls into a high-risk class and may require a pharmacist s intervention if there is a discrepancy noted during the medication reconciliation? a. apixaban b. hydrocodone c. glipizide d. All of the above

8 Pre-Test Question 4 1. Which directions for use (Sig codes) require further clarification according to the Institute for Safe Medication Practices (ISMP)? Choose all that apply: a. MgSO 4 4.0g IV qd b. lisinopril 40 mg po daily c. APAP 500 mg po q 4 6 hours PRN pain d. lorazepam.5 mg po qhs

9 Background Adverse drug events (ADEs) are at the greatest risk of occurring during care transitions There is a reported range of inpatient medication errors from 45% - 76% The Joint Commission and National Patient Safety Goal In medication reconciliation, a clinician compares the medications a patient should be using (and is actually using) to the new medications that are ordered for the patient and resolves any discrepancies. American College of Clinical Pharmacy, et al. Pharmacotherapy Nov;32(11):e Sen S, et al. Am J Health Syst Pharm Jan 1;71(1):51-6. The Joint Commission. Hospital National Patient Safety Goals; 2015.

10 Definitions Medication Reconciliation: A clinician compares the medications a patient should be using (and is actually using) to the new medications that are ordered for the patient and resolves any discrepancies. The process of creating the most accurate list possible of all medications a patient is taking including drug name, dosage, frequency, and route and comparing that list against the physician s admission, transfer, and/or discharge orders, with the goal of providing correct medications to the patient at all transition points within the hospital. The Joint Commission. Hospital National Patient Safety Goals; Institute for Healthcare Improvement

11 Definitions Transitions of Care: At admission, transfer, and discharge Transitions in care both within and outside of an organization A transfer of care At admission (both into the Emergency Department and then to inpatient status) At transfer of care within the hospital (to a different unit or new care provider) At discharge Institute for Healthcare Improvement The Joint Commission. Hospital National Patient Safety Goals; 2015.

12 HSHS St. Elizabeth s Hospital Belleville, Illinois Community-based teaching institute Decentralized pharmacy model with inter-professional patient rounds and clinical pharmacy services Dedicated Emergency Department Pharmacist Dedicated Emergency Department Pharmacy Technicians

13 Why Pharmacy? Pharmacists are consistently ranked Pharmacists as one Pharmacists of are the the most are trusted the accessible of all MEDICATION professions health care by professionals. EXPERTS. Gallup. ml-law.net Ml-law.net

14 Data Supporting Pharmacy Gleason and colleagues estimated that the cost of potential harm avoided by pharmacists conducting medication reconciliation was almost $39,000 Gleason et al. Am J Health Syst Pharm Aug 15;61(16): Gleason et al. J Gen Intern Med May;25(5): Schnipper et al. Arch Intern Med Mar 13;166(5):

15 Data Supporting Pharmacy In the MATCH study, physician-obtained medication history was the source of error more often than in pharmacist-obtained medication histories Gleason et al. Am J Health Syst Pharm Aug 15;61(16): Gleason et al. J Gen Intern Med May;25(5): Schnipper et al. Arch Intern Med Mar 13;166(5):

16 Data Supporting Pharmacy Schnipper and colleagues found that when a pharmacist provided discharge counseling and follow-up with a pharmacist, readmissions and emergency department visits decreased significantly from 8% to 1% Gleason et al. Am J Health Syst Pharm Aug 15;61(16): Gleason et al. J Gen Intern Med May;25(5): Schnipper et al. Arch Intern Med Mar 13;166(5):

17 Data Supporting Pharmacy Levitz found that after 2 years of pharmacy technicians conducting medication reconciliations, the medication error rate decreased from 50% to <5% Levitz MD. Pharmacy Times August. Sen et al. Am J Health Syst Pharm Jan 1;71(1):51-6. Michels et al. Am J Health Syst Pharm Oct 1;60(19):

18 Data Supporting Pharmacy Sen et al demonstrated that a pharmacy technician-centered MR (PTMR) program identified a similar number of discrepancies as when pharmacist-conducted Levitz MD. Pharmacy Times August. Sen et al. Am J Health Syst Pharm Jan 1;71(1):51-6. Michels et al. Am J Health Syst Pharm Oct 1;60(19):

19 Data Supporting Pharmacy Michaels and colleagues decreased potential ADEs by > 80% by having a pharmacy technician conduct the medication reconciliation Levitz MD. Pharmacy Times August. Sen et al. Am J Health Syst Pharm Jan 1;71(1):51-6. Michels et al. Am J Health Syst Pharm Oct 1;60(19):

20 Getting Started 1. Policy and Procedure Development 2. Implementation and Performance Improvement 3. Training and Competency Assurance 4. Information Systems Development 5. Advocacy American Society of Health-System Pharmacists. Am J Health-Syst Pharm. 2013;70:453-6.

21 Getting Started- Planning 1. Location Location Location - A specific unit - A specific disease state - A specific transition 2. Who will be involved - Pharmacist - Pharmacy Technician - Nurses/Managers/Physicians - Patient American Society of Health-System Pharmacists et al. Best practices from the ASHP-APhA medication management in care transitions initiative Feb.

22 Getting Started- Planning 3. Determine current Medication Reconciliation Work Flow - Don t duplicate efforts 4. Look for Areas to Improve/Streamline Work Flow 5. Pick a Date for Implementation American Society of Health-System Pharmacists et al. Best practices from the ASHP-APhA medication management in care transitions initiative Feb.

23 Common Barriers 1. Cost 2. Manpower 3. Increased Workload 4. Appropriate Training 5. Lack of standardized discharge order cut-off time 6. Technological Barriers 7. Lack of Continuity to the Ambulatory Care Setting American Society of Health-System Pharmacists et al. Best practices from the ASHP-APhA medication management in care transitions initiative Feb.

24 Technology

25 Technology

26 Use of Pharmacy Technicians Choose Pharmacy Technicians with experience Strong communication skills are necessary Adequate supervision during training Clear work flow process and when pharmacist involvement is required Documentation Michels et al. Am J Health Syst Pharm Oct 1;60(19): Sen et al. Am J Health Syst Pharm Jan 1;71(1):51-6.

27 Use of Pharmacy Technicians Date Tech Column1 # of Meds Missing Documentation w/ Alert Missing Documentation w/o Alert Meds with Complete Documentation Last Taken Field Not Addressed Last Taken Field Addressed Total Errors Error Rate Auditing Comments Jan INPUT MILK OF MAGNESIUM PRN CONGESTION Jan Jan Jan Jan Jan Jan Jan Jan Jan Jan Jan Jan Jan Jan Jan Jan Jan Jan Jan Jan Jan Jan Jan Jan Jan Jan Jan Jan Jan

28 Use of Pharmacy Technicians Date Tech Medical Record # Jan-16 Sally Smith, Technician Jan-16 Sally Smith, Technician Jan-16 Sally Smith, Technician Jan-16 Sally Smith, Technician Jan-16 Sally Smith, Technician Jan-16 Sally Smith, Technician Jan-16 Sally Smith, Technician Jan-16 Sally Smith, Technician Jan-16 Sally Smith, Technician Jan-16 Sally Smith, Technician

29 Use of Pharmacy Technicians DateTech Medical Record # of # Meds Missing Docum entatio n w/ Alert Missing Documen tation w/o Alert Meds with Complete Documen -tation Last Taken Field Not Addressed Last Taken Field Addressed Total Errors Error Rate Jan Jan Jan Jan Jan Auditing Comments INPUT MILK OF MAGNESIUM PRN CONGESTION

30 Use of Pharmacy Technicians

31 Use of Pharmacy Technicians DateTech Medical Record # of # Meds Missing Docum entatio n w/ Alert Missing Documen tation w/o Alert Meds with Complete Documen -tation Last Taken Field Not Addressed Last Taken Field Addressed Total Errors Error Rate Jan Jan Jan Jan Jan Auditing Comments INPUT MILK OF MAGNESIUM PRN CONGESTION

32 Use of Pharmacy Technicians

33 Use of Pharmacy Technicians DateTech Medical Record # of # Meds Missing Docum entatio n w/ Alert Missing Documen tation w/o Alert Meds with Complete Documen -tation Last Taken Field Not Addressed Last Taken Field Addressed Total Errors Error Rate Jan Jan Jan Jan Jan Auditing Comments INPUT MILK OF MAGNESIUM PRN CONGESTION

34 Use of Pharmacy Technicians

35 Use of Pharmacy Technicians High Alert Medications Antiarrhythmics Antithrombotics Chemotherapeutic Agents Hypoglycemics, oral and IM Insulins Opioids Institute for Safe Medication Practices. Accessed June 10, Institute for Safe Medication Practices. Accessed June 10, 2016.

36 Use of Pharmacy Technicians Error-Prone Abbreviations, Symbols and Dose Designations qd qhs U Inderal40 10mg MgSO 4 APAP Institute for Safe Medication Practices. Accessed June 10, Institute for Safe Medication Practices. Accessed June 10, 2016.

37 Next Steps HSHS Medical Group Ambulatory Care Clinic Focus on medication reconciliation from inpatient to outpatient Report back

38 Post-Test Question 1 1. Medication reconciliations at TOC are important because: a. The Joint Commission has designated inpatient medication reconciliation as a National Patient Safety Goal b. Errors such as omissions and duplications, dosing changes and new drug-drug interactions can significantly compromise patient safety c. Readmission rates and medication errors decline overall when medications are reconciled d. All of the above

39 Post-Test Question 2 1. When should a TOC medication reconciliation occur? Choose all that apply: a. Upon emergency department admission b. Upon inpatient admission c. Upon transfer from one unit to another d. Upon transfer from one room to another within the same unit

40 Post-Test Question 3 1. Which medication falls into a high-risk class and may require a pharmacist s intervention if there is a discrepancy noted during the medication reconciliation? a. apixaban b. hydrocodone c. glipizide d. All of the above

41 Post-Test Question 4 1. Which directions for use (Sig codes) require further clarification according to the Institute for Safe Medication Practices (ISMP)? Choose all that apply: a. MgSO 4 4.0g IV qd b. lisinopril 40 mg po daily c. APAP 500 mg po q 4 6 hours PRN pain d. lorazepam.5 mg po qhs PRN sleep MgSO 4 can be confused for MSO 4 ; never put a trailing zero after decimal point; always put a space between dose and unit of measure; never use qd as it can be mistaken for qid APAP may not be recognized as acetaminophen Always use a leading zero prior to the decimal point; qhs should not be used as it can be confused with qhr or half-strength

42 Acknowledgements Pharmacy staff at HSHS St. Elizabeth s Hospital Michael Randazzo, PharmD

43 References American College of Clinical Pharmacy, Hume AL, Kirwin J, Bieber HL, Couchenour RL, Hall DL, Kennedy AK, LaPointe NM, Burkhardt CD, Schilli K, Seaton T, Trujillo J, Wiggins B. Improving care transitions: current practice and future opportunities for pharmacists. Pharmacotherapy Nov;32(11):e American Pharmacists Association, American Society of Health-System Pharmacists, Steeb D, Webster L. Improving care transitions: optimizing medication reconciliation. J Am Pharm Assoc Jul-Aug;52(4):e American Society of Health-System Pharmacists, American Pharmacists Association, Cassano A. Best practices from the ASHP-APhA medication management in care transitions initiative Feb. American Society of Health-System Pharmacists. ASHP statement on the pharmacist s role in medication reconciliation. Am J Health-Syst Pharm. 2013;70: Erickson AK. Transitions of care: the next frontier for hospital and community-based pharmacist. Pharmacy Today April;22(4):34-7. Gleason KM, Brake H, Agramonte V, Perfetti C. Medications at transitions and clinical handoffs (MATCH) toolkit for medication reconciliation. AHRQ Publication No. 11(12) Rockville, MD: Agency for Healthcare Research and Quality. December Gleason KM, Groszek JM, Sullivan C, Rooney D, Barnard C, Noskin GA. Reconciliation of discrepancies in medication histories and admission orders of newly hospitalized patients. Am J Health Syst Pharm Aug 15;61(16): Gleason KM, McDaniel MR, Feinglass J, Baker DW, Lindquist L, Liss D, Noskin GA. Results of the Medications at Transitions and Clinical Handoffs (MATCH) study: an analysis of medication reconciliation errors and risk factors at hospital admission. J Gen Intern Med May;25(5): Hall S. Case Study: medication reconciliation by pharmacy technicians, student interns. Pharmacy Practice Model Initiative. Accessed June 14, 2016.

44 References Institute for Safe Medication Practices. ISMP s list of error-prone abbreviations, symbols, and dose designations. Accessed June 10, Institute for Safe Medication Practices. ISMP s list of high-alert medications in acute care settings. Accessed June 10, Levitz MD. Medication reconciliation: the role of the pharmacy technician. Pharmacy Times August. Accessed June 10,2016. Michels RD, Meisel SB. Program using pharmacy technicians to obtain medication histories. Am J Health Syst Pharm Oct 1;60(19): Sen S, Bowen JF, Ganetsky VS, Hadley D, Melody K, Otsuka S, Vanmali R, Thomas T. Pharmacists implementing transitions of care in inpatient, ambulatory and community practice settings. Pharm Pract Apr;12(2):439. Schnipper JL, Kirwin JL, Cotugno MC, Wahlstrom SA, Brown BA, Tarvin E, Kachalia A, Horng M, Roy CL, McKean SC, Bates DW. Role of pharmacist counseling in preventing adverse drug events after hospitalization. Arch Intern Med Mar 13;166(5): Sen S, Siemianowski L, Murphy M, McAllister SC. Implementation of a pharmacy technician-centered medication reconciliation program at an urban teaching medical center. Am J Health Syst Pharm Jan 1;71(1):51-6. The Joint Commission, The Joint Commission International, World Health Organization. Assuring medication accuracy at transitions in care. Patient Safety Solutions May;1(6)

45 Speaker Contact Information Julie H. McGinley, PharmD, MHS

46 Improving Patient Safety through Pharmacist- and Pharmacy Technician-Driven Medication Reconciliations at Transitions of Care Julie H. McGinley, PharmD, MHS Southern Illinois University Edwardsville, School of Pharmacy

Pharmacist Objectives. Technician Objectives. Pre-Test Question 2. Pre-Test Question 1. Disclosure and Conflict of Interest

Pharmacist Objectives. Technician Objectives. Pre-Test Question 2. Pre-Test Question 1. Disclosure and Conflict of Interest Disclosure and Conflict of Interest Improving Patient Safety through Pharmacist-and Pharmacy Technician-Driven Medication Reconciliations at Transitions of Care Julie H. McGinley, PharmD, MHS Southern

More information

Justifying New Oncology Pharmacist Positions

Justifying New Oncology Pharmacist Positions Faculty Disclosures Justifying New Oncology Pharmacist Positions I will not be discussing off-label uses of any medications I am on the speaker s bureau for Millenium Pharmaceuticals and am a paid consultant

More information

Chemotherapy regimen checks performed by pharmacists contribute to safe administration of chemotherapy

Chemotherapy regimen checks performed by pharmacists contribute to safe administration of chemotherapy Original Article Chemotherapy regimen checks performed by pharmacists contribute to safe administration of chemotherapy J Oncol Pharm Practice 2017, Vol. 23(1) 18 25! The Author(s) 2015 Reprints and permissions:

More information

Med Wreck to Med Rec How medication reconciliation can (should) change your practice!

Med Wreck to Med Rec How medication reconciliation can (should) change your practice! Med Wreck to Med Rec How medication reconciliation can (should) change your practice! Dan Martinusen BSc(Pharm),ACPR, PharmD Chair, BCPRA Pharmacy & Formulary Committee Marianna Leung B Sc(Pharm), ACPR,

More information

Transitions of Care & Medication Reconciliation Ashley King, PharmD, BCGP Clinical Pharmacist LECOM Health March 2018

Transitions of Care & Medication Reconciliation Ashley King, PharmD, BCGP Clinical Pharmacist LECOM Health March 2018 Transitions of Care & Medication Reconciliation Ashley King, PharmD, BCGP Clinical Pharmacist LECOM Health March 2018 Objectives Identify when to complete medication reconciliation Understand the importance

More information

Maryland Patient Safety Center s Annual MEDSAFE Conference: Taking Charge of Your Medication Safety Challenges November 3, 2011 The Conference Center

Maryland Patient Safety Center s Annual MEDSAFE Conference: Taking Charge of Your Medication Safety Challenges November 3, 2011 The Conference Center Maryland Patient Safety Center s Annual MEDSAFE Conference: Taking Charge of Your Medication Safety Challenges November 3, 2011 The Conference Center at the Maritime Institute Pharmacy-Driven Inpatient

More information

Pain Management and Safe use of opioids in hospitals. Kyoung-Sil Kang, PharmD, BCPS Scott Tam, PharmD Lauve Casimir, RN, MSN

Pain Management and Safe use of opioids in hospitals. Kyoung-Sil Kang, PharmD, BCPS Scott Tam, PharmD Lauve Casimir, RN, MSN Pain Management and Safe use of opioids in hospitals Kyoung-Sil Kang, PharmD, BCPS Scott Tam, PharmD Lauve Casimir, RN, MSN Bronx Care Health System Bronx Lebanon Hospital Concourse/ Fulton division, Nursing

More information

Hospital Transition Management. Barbara Wood, BSN, MBA

Hospital Transition Management. Barbara Wood, BSN, MBA Hospital Transition Management Barbara Wood, BSN, MBA Director, Embedded Care Management Programs OBJECTIVES Improve health care quality for our patients by streamlining care transitions Reduce avoidable

More information

Reducing COPD Exacerbation Readmissions in a Community-Based Teaching Hospital

Reducing COPD Exacerbation Readmissions in a Community-Based Teaching Hospital Reducing COPD Exacerbation Readmissions in a Community-Based Teaching Hospital Dawn Waddell, PharmD, BCPS Clinical Pharmacy Manager Lisa Kingdon, PharmD, BCPS Clinical Pharmacy Specialist Dawn Waddell

More information

Reducing the risk of patient harm: A focus on opioids

Reducing the risk of patient harm: A focus on opioids Reducing the risk of patient harm: A focus on opioids New York State Partnership for Patients (NYSPFP) Initiative Regional Educational Session November 2013 1 Disclosure Matthew Fricker, Matthew Grissinger,

More information

Disclosures. Learning Objectives 4/26/2017

Disclosures. Learning Objectives 4/26/2017 Implementation of a quality improvement initiative to ensure the safe transition from prior-to-admission concentrated insulins to a formulary insulin regimen ERICA J. RHEIN, PHARMD PGY1 PHARMACY PRACTICE

More information

Conflict of Interest Declaration. High Risk Medications in the Hospital Pharmacy. According to. Learning Objectives. Medication Safety Organizations

Conflict of Interest Declaration. High Risk Medications in the Hospital Pharmacy. According to. Learning Objectives. Medication Safety Organizations Conflict of Interest Declaration High Risk Medications in the Hospital Pharmacy None to disclose Monika Gil, Pharm.D. Clinical Staff Pharmacist Rush University Medical Center Chicago, IL Learning Objectives

More information

Error Prevention Measurement Methodology

Error Prevention Measurement Methodology Error Prevention Measurement Methodology January 1 to June 30, 2008 Version 9.0a Updated for ICD-9 CM and CPT Code Changes Effective January 1, 2008 Questions or comments can be directed to Bob Beaverson

More information

From medicines reconciliation to medicines review. Dr. Fatma Karapinar Hospital pharmacistepidemiologist

From medicines reconciliation to medicines review. Dr. Fatma Karapinar Hospital pharmacistepidemiologist From medicines reconciliation to medicines review Dr. Fatma Karapinar Hospital pharmacistepidemiologist Conflict of interest Nothing to disclose Questions Medication review is more important than medicines

More information

Patient Perceptions and Effects of Single Community Pharmacy Systems: Key Elements for Transitions of Care

Patient Perceptions and Effects of Single Community Pharmacy Systems: Key Elements for Transitions of Care Journal of Pharmacy and Pharmacology 4 (2016) 248-252 doi: 10.17265/2328-2150/2016.06.002 D DAVID PUBLISHING Patient Perceptions and Effects of Single Community Pharmacy Systems: Key Elements for Transitions

More information

IMPROVING MEDICATION SAFETY AMONG ELDERLY PATIENTS IN AN AMBULATORY SETTING. Alyssa Berry, Rebecca Burgett, Erin Day, Aron Hrubetz

IMPROVING MEDICATION SAFETY AMONG ELDERLY PATIENTS IN AN AMBULATORY SETTING. Alyssa Berry, Rebecca Burgett, Erin Day, Aron Hrubetz IMPROVING MEDICATION SAFETY AMONG ELDERLY PATIENTS IN AN AMBULATORY SETTING Alyssa Berry, Rebecca Burgett, Erin Day, Aron Hrubetz Improving Medication Safety Among Elderly Patients in an Ambulatory Setting

More information

North Dakota Board of Pharmacy

North Dakota Board of Pharmacy North Dakota Board of Pharmacy Updates on Drug Abuse Trends, the PDMP and Medical Marijuana Mark J. Hardy, Pharm D Executive Director Disclosure Statement I have no conflict of interests to report Objectives

More information

Identifying and reducing medication errors in mental health

Identifying and reducing medication errors in mental health Identifying and reducing medication errors in mental health Hilary Scott Chief Pharmacist South Essex Partnership University NHS Trust with valuable input from Ian Maidment, Senior Lecturer in Clinical

More information

Cardiology Pharmacist. Melanie Madorsky, PharmD, BCPS TSHP Annual Meeting April 7, 2018

Cardiology Pharmacist. Melanie Madorsky, PharmD, BCPS TSHP Annual Meeting April 7, 2018 Cardiology Pharmacist Melanie Madorsky, PharmD, BCPS TSHP Annual Meeting April 7, 2018 Melanie.Madorsky@memorialhermann.org Objectives Explain the daily responsibilities of the Cardiology Pharmacist Identify

More information

Quit rates among smokers who received pharmacist-provided pharmacotherapy and quitline services versus those who received only quitline services.

Quit rates among smokers who received pharmacist-provided pharmacotherapy and quitline services versus those who received only quitline services. Quit rates among smokers who received pharmacist-provided pharmacotherapy and quitline services versus those who received only quitline services. Jill Augustine, PharmD, MPH 1 ; Ryan Seltzer, PhD 2 ; Martin

More information

PHARMACIST INVOLVEMENT IN HIV CARE. Alftan D. Dyson, Pharm.D., BCACP, AAHIVP Clinical Pharmacist, Medical Advocacy and Outreach

PHARMACIST INVOLVEMENT IN HIV CARE. Alftan D. Dyson, Pharm.D., BCACP, AAHIVP Clinical Pharmacist, Medical Advocacy and Outreach PHARMACIST INVOLVEMENT IN HIV CARE Alftan D. Dyson, Pharm.D., BCACP, AAHIVP Clinical Pharmacist, Medical Advocacy and Outreach Objectives Describe the unique role of pharmacists in patient education and

More information

SAFETY CONCERNS WITH MULTIPLE MEDICATIONS AND BEYOND. Sandra Brownstein, PharmD, CGP

SAFETY CONCERNS WITH MULTIPLE MEDICATIONS AND BEYOND. Sandra Brownstein, PharmD, CGP SAFETY CONCERNS WITH MULTIPLE MEDICATIONS AND BEYOND Sandra Brownstein, PharmD, CGP Objectives: List potential medication related problems that increase in the frail elderly with acute illness Differentiate

More information

What s at the Heart of the Matter?

What s at the Heart of the Matter? What s at the Heart of the Matter? Inpatient Pharmacy Services for Heart Failure Patients Jason Williamson, PharmD, BCPS Clinical Pharmacy Manager, PGY1 Pharmacy Residency Director Genesys Regional Medical

More information

Interventions unrelated to anticoagulation in a pharmacist-managed anticoagulation clinic

Interventions unrelated to anticoagulation in a pharmacist-managed anticoagulation clinic AJHP RESIDENTS EDITON INTERVENTIONS UNRELATED TO ANTICOAGULATION Interventions unrelated to anticoagulation in a pharmacist-managed anticoagulation clinic Michael D. Hicho, Pharm.D., BCPS, Emergency Department,

More information

New Approach to Reducing Adverse Drug Events Anticoagulants Insulin Opioids

New Approach to Reducing Adverse Drug Events Anticoagulants Insulin Opioids New Approach to Reducing Adverse Drug Events Anticoagulants Insulin Opioids October 9, 2013 A partnership of the Healthcare Association of New York State and the Greater New York Hospital Association NYSPFP

More information

Navigating the Road to Efficient Medication Use

Navigating the Road to Efficient Medication Use Navigating the Road to Efficient Medication Use Molly R. Sinert, RPh, PharmD Clinical Pharmacist HospiScript Services LLC a Catamaran Rx Company October 28, 2013 Objectives Describe the components of the

More information

Rina Ramirez, MD FACP Teresita Lawson, BSPharm, RPh, CDE

Rina Ramirez, MD FACP Teresita Lawson, BSPharm, RPh, CDE Rina Ramirez, MD FACP Teresita Lawson, BSPharm, RPh, CDE List three components for CPS Describe how to integrate CPS into the primary care team Explain how CPS aligns with PCMH and Meaningful Use Established

More information

Meds and Falls: Keep in Step with your Meds

Meds and Falls: Keep in Step with your Meds Meds and Falls: Keep in Step with your Meds Donna Bartlett PharmD, CGP, RPh Associate Professor-Pharmacy Practice MCPHS University Clinical Pharmacist-MCPHS University- Pharmacy Outreach Program donna.bartlett@mcphs.edu

More information

Best Practices in Acute Care Precepting at the Sharp Chula Vista Medical Center Medicine Rotation

Best Practices in Acute Care Precepting at the Sharp Chula Vista Medical Center Medicine Rotation Best Practices in Acute Care Precepting at the Sharp Chula Vista Medical Center Medicine Rotation Pratima Patel, PharmD Clinical Pharmacist Medicine Rotation Preceptor Sharp Chula Vista Medical Center

More information

Clarification of Drug Allergy Information Using a Standardized Drug Allergy Questionnaire and Interview

Clarification of Drug Allergy Information Using a Standardized Drug Allergy Questionnaire and Interview Clarification of Drug Allergy Information Using a Standardized Drug Allergy Questionnaire and Interview Amy Harig, PharmD, BCPS; Amy Rybarczyk, PharmD, BCPS; Amanda Benedetti, PharmD; and Jacob Zimmerman,

More information

Ensuring Safety of Anticoagulation Therapy

Ensuring Safety of Anticoagulation Therapy Ensuring Safety of Anticoagulation Therapy Abha Agrawal, MD, FACP Chief Medical Officer Kings County Hospital Clinical Associate Dean SUNY Downstate College of Medicine Brooklyn, NY NYACP Webinar April

More information

D DAVID PUBLISHING. 1. Introduction. Shannon Inglet 1, Michael Curcio 2 and Lada Radetic 3

D DAVID PUBLISHING. 1. Introduction. Shannon Inglet 1, Michael Curcio 2 and Lada Radetic 3 Journal of Pharmacy and Pharmacology 6 (2018) 197-201 doi: 10.17265/2328-2150/2018.03.001 D DAVID PUBLISHING Evaluation of Opioid Reversal with Naloxone before and after Implementation of a Computerized

More information

Implementation of an Interprofessional Team to Prevent Inpatient Hypoglycemic Events. September 13, 2016

Implementation of an Interprofessional Team to Prevent Inpatient Hypoglycemic Events. September 13, 2016 Implementation of an Interprofessional Team to Prevent Inpatient Hypoglycemic Events September 13, 2016 St Joseph s Health Fast Facts Founded 1869 by Sisters of St. Francis Patient Volumes (2014) Inpatient

More information

Robyn Tamblyn, BSCN MSc PhD May 2 nd, 2018 Baldwin Seminar Series Accreditation Council for Graduate Medical Education

Robyn Tamblyn, BSCN MSc PhD May 2 nd, 2018 Baldwin Seminar Series Accreditation Council for Graduate Medical Education Robyn Tamblyn, BSCN MSc PhD May 2 nd, 2018 Baldwin Seminar Series Accreditation Council for Graduate Medical Education Robyn Tamblyn, BScN, MSc, PhD, CM Disclosure None of the above speakers have any conflicts

More information

Do Not Use Abbreviations

Do Not Use Abbreviations Do Not Use Abbreviations The Institute for Safe Medication Practice (ISMP) and the Joint Commission (JACHO) have each developed a list of dangerous abbreviations. The list includes abbreviations considered

More information

Patient Safety in Older Adults

Patient Safety in Older Adults Patient Safety in Older Adults Scott Martin Vouri, PharmD, MSCI, BCPS, BCGP, FASCP St. Louis College of Pharmacy Faculty Disclosure Dr. Vouri is funded by the Washington University Institute of Clinical

More information

Patient Safety in Older Adults

Patient Safety in Older Adults Patient Safety in Older Adults Scott Martin Vouri, PharmD, MSCI, BCPS, BCGP, FASCP St. Louis College of Pharmacy Faculty Disclosure Dr. Vouri is funded by the Washington University Institute of Clinical

More information

2/9/2016. A Multi-Disciplinary Program to Decrease the Rate of Preventable Harm from Medication Events. Objectives:

2/9/2016. A Multi-Disciplinary Program to Decrease the Rate of Preventable Harm from Medication Events. Objectives: A Multi-Disciplinary Program to Decrease the Rate of Preventable Harm from Medication Events Michigan Pharmacist Association February 28, 2016 Steven Johnson, Pharm.D. Regional Clinical Director Gay Alcenius,

More information

Error Reduction Strategies for High-Alert Medications Kelly Besco, Pharm.D., FISMP, CPPS

Error Reduction Strategies for High-Alert Medications Kelly Besco, Pharm.D., FISMP, CPPS Error Reduction Strategies for High-Alert Medications Kelly Besco, Pharm.D., FISMP, CPPS Medication Safety Officer OhioHealth Pharmacy Services Conflict of Interest Disclosure Kelly Besco declares no conflicts

More information

3/17/2017. Innovative Opportunities for Pharmacists in the Evolving World of Healthcare. Elderly represent about of our emergency medical services:

3/17/2017. Innovative Opportunities for Pharmacists in the Evolving World of Healthcare. Elderly represent about of our emergency medical services: Innovative Opportunities for Pharmacists in the Evolving World of Healthcare Christina Pornprasert, PharmD Population Health Clinical Pharmacist Hartford Healthcare Integrated Care Partners Addolorata

More information

Innovative Opportunities for Pharmacists in the Evolving World of Healthcare

Innovative Opportunities for Pharmacists in the Evolving World of Healthcare Innovative Opportunities for Pharmacists in the Evolving World of Healthcare Christina Pornprasert, PharmD Population Health Clinical Pharmacist Hartford Healthcare Integrated Care Partners Assistant Clinical

More information

THE QUEEN ELIZABETH HOSPITAL The Do Not Use List aka ISMP s List of Error-Prone Abbreviations, Symbols, and Dose Designations

THE QUEEN ELIZABETH HOSPITAL The Do Not Use List aka ISMP s List of Error-Prone Abbreviations, Symbols, and Dose Designations Abbreviation to be avoided Potential Problem µg Microgram Mistaken for mg (milligrams) resulting in one thousand fold dosing overdose. IU International Mistaken for IV (intravenous) or 10 unit (ten). A.S.,

More information

Annotation Guidelines for the Adverse Drug Event (ADE) and Medication Extraction Challenge

Annotation Guidelines for the Adverse Drug Event (ADE) and Medication Extraction Challenge Annotation Guidelines for the Adverse Drug Event (ADE) and Medication Extraction Challenge 1. Overview Written by Kevin Buchan Edited by Marilena Di Bari and Amber Stubbs The task hereby proposed is aimed

More information

Carla Cobb, Pharm.D., BCPP Helena, MT September *Funded by the Montana Healthcare Foundation

Carla Cobb, Pharm.D., BCPP Helena, MT September *Funded by the Montana Healthcare Foundation Carla Cobb, Pharm.D., BCPP Helena, MT September 2016 *Funded by the Montana Healthcare Foundation Why Are We Here? Pharmacists The Most Underutilized Healthcare Professional Gaps in Care Hypertension Hyperlipidemia

More information

Addressing Medication Errors in HIV-Positive Inpatients: A Clinician s Guide to Assessing Antiretroviral Therapy

Addressing Medication Errors in HIV-Positive Inpatients: A Clinician s Guide to Assessing Antiretroviral Therapy Addressing Medication Errors in HIV-Positive Inpatients: A Clinician s Guide to Assessing Antiretroviral Therapy Emily Li, BScPharm, PharmD Candidate 1 Elliot Pittman, BScPharm, PharmD Candidate 1 Michelle

More information

Risk Management in Parenteral Nutrition. J. Boullata

Risk Management in Parenteral Nutrition. J. Boullata Risk Management in Parenteral Nutrition J. Boullata Objectives Upon completion of this session, the participant will be able to: Describe safety issues with parenteral nutrition (PN) Present the PN-use

More information

Suicide Prevention: From a Pharmacist s Perspective. Daina L. Wells, Pharm.D., BCPS, BCPP VA PBM Academic Detailing Service

Suicide Prevention: From a Pharmacist s Perspective. Daina L. Wells, Pharm.D., BCPS, BCPP VA PBM Academic Detailing Service Suicide Prevention: From a Pharmacist s Perspective Daina L. Wells, Pharm.D., BCPS, BCPP VA PBM Academic Detailing Service CPE Information and Disclosures Daina L. Wells declare(s) no conflicts of interest,

More information

Publication List Publication tracking PubMed ResearcherID ORCID http://www.ncbi.nlm.nih.gov/pubmed/?term=beeler+pe[author] http://www.researcherid.com/rid/a-6143-2016 http://orcid.org/0000-0002-6097-2480

More information

Medication Reconciliation On Admission

Medication Reconciliation On Admission Medication Reconciliation On Admission Lions Gate Hospital May 15, 2012 Mary Shyng Medication Safety Pharmacist - Coastal Medication Reconciliation Working Definition: a formal, systematic process in which

More information

Empowering Older Adults On Drug Adherence A Collaborative Service Model. Cheng Po-po, Peggy Nurse Consultant (Gerontology) Yan Chai Hospital, KWC, HA

Empowering Older Adults On Drug Adherence A Collaborative Service Model. Cheng Po-po, Peggy Nurse Consultant (Gerontology) Yan Chai Hospital, KWC, HA Empowering Older Adults On Drug Adherence A Collaborative Service Model Cheng Po-po, Peggy Nurse Consultant (Gerontology) Yan Chai Hospital, KWC, HA Introduction Older adults have multiple pathologies

More information

Medication Safety. Patient Safety. Setting Direction Julie Simmons, Medication Safety Pharmacist January 2016

Medication Safety. Patient Safety. Setting Direction Julie Simmons, Medication Safety Pharmacist January 2016 Medication Safety Patient Safety Setting Direction Julie Simmons, Medication Safety Pharmacist January 2016 1 The patient journey Admission Ward Transfer Ward stay Discharge Medication storage and supply

More information

Reducing Intermittent Infusion Syringe Pump Errors via Weight-Based Safety Parameters

Reducing Intermittent Infusion Syringe Pump Errors via Weight-Based Safety Parameters Reducing Intermittent Infusion Syringe Pump Errors via Weight-Based Safety Parameters Alison Bloomquist and Laura Seiberlich Abstract Historically, smart infusion pumps with dose error reduction software

More information

ISMP QuarterlyActionAgenda

ISMP QuarterlyActionAgenda One of the most important ways to prevent medication errors is to learn about problems that have occurred in other organizations and to use that information to prevent similar problems at your practice

More information

Nuts for Neuro and why I hate EMR

Nuts for Neuro and why I hate EMR Nuts for Neuro and why I hate EMR Roberta S Rose, DO private practice in General neurology Staff physician: IRMC and SRMC I have no disclosures, I m just a working stiff Stroke overview: 2018 Guidelines

More information

Reducing Readmissions and Improving Outcomes at OhioHealth Mansfield Hospital:

Reducing Readmissions and Improving Outcomes at OhioHealth Mansfield Hospital: Reducing Readmissions and Improving Outcomes at OhioHealth Mansfield Hospital: Eugenio H. Zabaleta, Ph.D. Clinical Chemist OhioHealth Mansfield Hospital Reducing Readmissions and Improving Outcomes at

More information

Evaluation of National Academic Detailing Service on Naloxone Kit Prescription Rates in the Veterans Health Administration

Evaluation of National Academic Detailing Service on Naloxone Kit Prescription Rates in the Veterans Health Administration Evaluation of National Academic Detailing Service on Naloxone Kit Prescription Rates in the Veterans Health Administration Melissa LD Christopher, PharmD National Director Academic Detailing Program Office

More information

Potential disruption from private exchanges and narrow networks. In 2011, less than 10% of companies used High Performing Networks (narrow networks)

Potential disruption from private exchanges and narrow networks. In 2011, less than 10% of companies used High Performing Networks (narrow networks) 1 3 2 Potential disruption from private exchanges and narrow networks. In 2011, less than 10% of companies used High Performing Networks (narrow networks) and in 2014 estimated to be 40%. By 2018, that

More information

Opioid Overdose Education and Naloxone Distribution

Opioid Overdose Education and Naloxone Distribution Opioid Overdose Education and Naloxone Distribution Emily Stoukides, PharmD PGY-2 Ambulatory Care Pharmacy Resident Nicole Brunet, PharmD, BCPP Clinical Pharmacy Specialist, Mental Health Disclosures Emily

More information

Determinants and frequency of pharmaceutical compounding in pharmacy practice in Palestine

Determinants and frequency of pharmaceutical compounding in pharmacy practice in Palestine Research Paper Determinants and frequency of pharmaceutical compounding in pharmacy practice in Palestine Abdel Naser Zaid a, Rowa Al-Ramahi b, Qusai Shahed c, Belal Saleh c and Josephean Elaraj b Departments

More information

Disclosure Statement. Learning Objectives. Background. Background 4/26/2016

Disclosure Statement. Learning Objectives. Background. Background 4/26/2016 Disclosure Statement Implementation of Education plus Provider- Specific Prescribing Reports and the Effects on Antipsychotic Polypharmacy in Children and Adolescents with Mental Illness in an Outpatient

More information

Insulin Administration Errors in Adult Community Nursing. Hedy Lehman Assistant Director of Professional Standards, Adult Community Nursing

Insulin Administration Errors in Adult Community Nursing. Hedy Lehman Assistant Director of Professional Standards, Adult Community Nursing Insulin Administration Errors in Adult Community Nursing Hedy Lehman Assistant Director of Professional Standards, Adult Community Nursing Organisational Background, Changes and Context Prior to April

More information

US Public Health Services and US Coast Guard Breakout: Pharmacy II. CDR Robert Boyle Clinical Pharmacist, USPHS Salt River Integrated Health Care

US Public Health Services and US Coast Guard Breakout: Pharmacy II. CDR Robert Boyle Clinical Pharmacist, USPHS Salt River Integrated Health Care US Public Health Services and US Coast Guard Breakout: Pharmacy II Pharmacist Collaboration in a Hemodialysis Setting CDR Robert Boyle Clinical Pharmacist, USPHS Salt River Integrated Health Care CPE Information

More information

Disclosure. Objectives. Roles and Responsibilities. Medication Reconciliation

Disclosure. Objectives. Roles and Responsibilities. Medication Reconciliation 47 th Annual Meeting August 2-4, 2013 Orlando, FL The Evolving Role of the Pharmacy Technician: The Clinical Pharmacy Technician Roma Merrick RPhT., CPhT Pharmacy Technician Coordinator St. Vincent s Medical

More information

How Normal Business Operations Can Enhance Disaster Response and Community Resiliency

How Normal Business Operations Can Enhance Disaster Response and Community Resiliency How Normal Business Operations Can Enhance Disaster Response and Community Resiliency Xxxxx-xx/Footer The American Society for Automation in Pharmacy January 16, 2014-1 - Disclosures Erin Mullen is an

More information

Fact. Objectives 1/6/2016. Reducing Hospital Readmissions for Chronic Obstructive Pulmonary Disease (COPD)

Fact. Objectives 1/6/2016. Reducing Hospital Readmissions for Chronic Obstructive Pulmonary Disease (COPD) Reducing Hospital Readmissions for Chronic Obstructive Pulmonary Disease (COPD) Jin S. Oh, PharmD Larkin Community Hospital January 10, 2016 Fact COPD is the third leading cause of death in the United

More information

Impact of an Interactive Online Nursing Educational Module on Insulin Errors in Hospitalized Pediatric Patients

Impact of an Interactive Online Nursing Educational Module on Insulin Errors in Hospitalized Pediatric Patients Diabetes Care Publish Ahead of Print, published online May 26, 2010 Impact of an Interactive Online Nursing Educational Module on Insulin Errors in Hospitalized Pediatric Patients Short Title: Impact of

More information

Medication Therapy Management Solution

Medication Therapy Management Solution Medication Therapy Management Solution A Medicaid Case Report It s often challenging to include evidencebased clinical programs that offer financial benefits. However, pharmacotherapy is central to the

More information

Research Implementation Office (RIO) Solid Tumor/Heme/Heme Malignancy Protocol Specific Pre printed Order (PPO) Guidelines

Research Implementation Office (RIO) Solid Tumor/Heme/Heme Malignancy Protocol Specific Pre printed Order (PPO) Guidelines Research Implementation Office Solid Tumor/Heme/Heme Malignancy Protocol Specific Pre printed Order (PPO) Guidelines Note: As of February 11, 2015, the only preprinted orders which remain on paper for

More information

Drug Prescribing. Ravi Menon

Drug Prescribing. Ravi Menon Drug Prescribing Ravi Menon Introduction Approximately 7,000 individual drug doses are administered each day in a 'typical' NHS hospital, 70% of which are prescribed by first year graduates and senior

More information

IMPLEMENTING RECOVERY ORIENTED CLINICAL SERVICES IN OPIOID TREATMENT PROGRAMS PILOT UPDATE. A Clinical Quality Improvement Program

IMPLEMENTING RECOVERY ORIENTED CLINICAL SERVICES IN OPIOID TREATMENT PROGRAMS PILOT UPDATE. A Clinical Quality Improvement Program IMPLEMENTING RECOVERY ORIENTED CLINICAL SERVICES IN OPIOID TREATMENT PROGRAMS PILOT UPDATE A Clinical Quality Improvement Program Today: National completion rates for OTP s hover between 11 14% Retention

More information

Dispensing Patient- Speci/ic Insulin. Paul Parchesky, RPh Pharmacy Manager Newport Hospital November 1, 2014

Dispensing Patient- Speci/ic Insulin. Paul Parchesky, RPh Pharmacy Manager Newport Hospital November 1, 2014 Dispensing Patient- Speci/ic Insulin Paul Parchesky, RPh Pharmacy Manager Newport Hospital November 1, 2014 Goals Background on insulin dispensing at Newport Hospital Reasons for change Purchasing pacerns

More information

Using CURES to combat prescription drug abuse/misuse

Using CURES to combat prescription drug abuse/misuse Using CURES to combat prescription drug abuse/misuse Speakers Nathan Painter PharmD, CDE Email: npainter@ucsd.edu Rabia Atayee, PharmD, BCPS Email: ratayee@ucsd.edu UC San Diego Skaggs School of Pharmacy

More information

Patient Harm with Opioids: Can We Truly Reduce the Risk? Ali-Reza Shah-Mohammadi, PharmD, MS, FISMP

Patient Harm with Opioids: Can We Truly Reduce the Risk? Ali-Reza Shah-Mohammadi, PharmD, MS, FISMP Patient Harm with Opioids: Can We Truly Reduce the Risk? Ali-Reza Shah-Mohammadi, PharmD, MS, FISMP Clinical Pharmacy Specialist Medication Safety Pharmacy Medication Management & Analytics The University

More information

ACIP Recommendations for Adult Pneumococcal Immunization: Helping Pharmacists Assess, Recommend, Administer or Refer. Interim Outcomes Report

ACIP Recommendations for Adult Pneumococcal Immunization: Helping Pharmacists Assess, Recommend, Administer or Refer. Interim Outcomes Report ACIP Recommendations for Adult Pneumococcal Immunization: Helping Pharmacists Assess, Recommend, Administer or Refer Grant ID: 29025501 Interim Outcomes Report https://www.powerpak.com/course/preamble/114079

More information

Pharmacotherapy Issues in the Pediatric Population

Pharmacotherapy Issues in the Pediatric Population Pharmacotherapy Issues in the Pediatric Population Continuing Professional Pharmacy Development Dr. Shane Pawluk, PharmD Dr. Andrea Cartwright, PharmD Dr. Maryam Khaja March 26, 2014 Outline Didactic Session

More information

Risk Evaluation And Mitigation Strategies:

Risk Evaluation And Mitigation Strategies: Risk Evaluation And Mitigation Strategies: The Experts Answer Questions from Health-System Pharmacists A midday symposium about the risk evaluation and mitigation strategies (REMS) required by the Food

More information

Development of a Medication Discrepancy Classification System to Evaluate the Process of Medication Reconciliation (Work in progress)

Development of a Medication Discrepancy Classification System to Evaluate the Process of Medication Reconciliation (Work in progress) Development of a Medication Discrepancy Classification System to Evaluate the Process of Medication Reconciliation (Work in progress) Presented by Enas Almanasreh Supervisors: A/Prof. Timothy F Chen A/Prof.

More information

Statistical Press Notice NHS referral to treatment (RTT) waiting times data July 2017

Statistical Press Notice NHS referral to treatment (RTT) waiting times data July 2017 Thursday 14 September 2017 Statistical Press Notice NHS referral to treatment (RTT) waiting times data July 2017 NHS England released statistics today on referral to treatment (RTT) waiting times for consultant-led

More information

Nebraska: What s Going On with the PDMP and HIE

Nebraska: What s Going On with the PDMP and HIE Nebraska: What s Going On with the PDMP and HIE Kevin C. Borcher, PharmD PDMP Program Director NeHII, Inc. BJA PDMP North Regional Meeting October 16, 2018 Nebraska PDMP Legislative Summary LB 237 (2011)

More information

National Cancer Peer Review Programme

National Cancer Peer Review Programme National Cancer Peer Review Programme Julia Hill Acting Deputy National Co-ordinator What is Cancer Peer Review? A quality assurance process for cancer services. An integral part of Improving Outcomes

More information

The Art of Communicating Geriatric Vital Signs (An Age Friendly Health System Approach)

The Art of Communicating Geriatric Vital Signs (An Age Friendly Health System Approach) The Art of Communicating Geriatric Vital Signs (An Age Friendly Health System Approach) Michelle Moccia DNP, ANP-BC, CCRN Program Director, Senior ER St. Mary Mercy Hospital Livonia, MI michelle.moccia@stjoeshealth.org

More information

In Pursuit of Excellence: The CheckPoint Journey

In Pursuit of Excellence: The CheckPoint Journey Focus On Quality... In Pursuit of Excellence: The CheckPoint Journey Charles Shabino, MD; Dana Richardson, RN, MHA Abstract In March 2004, the Wisconsin Hospital Association launched CheckPoint sm (www.wicheckpoint.org)

More information

Tips and Tools to Drive Best Practice

Tips and Tools to Drive Best Practice Tips and Tools to Drive Best Practice Jaclyn Jeffries, PharmD Medication Safety Resident Center for Medication Safety Advancement Purdue University College of Pharmacy Indianapolis, IN Welcome and Overview

More information

Dr. Steve Ligertwood Dr. Roderick Tukker Dr. David Wilton

Dr. Steve Ligertwood Dr. Roderick Tukker Dr. David Wilton Dr. Steve Ligertwood Hospitalist Royal Columbian Hospital Regional Department Head-Hospitalist for Fraser Health Authority Project Lead BC Hospitalist VTE Collaborative Clinical Instructor, UBC School

More information

AWARENESS OF DENTISTS ABOUT MEDICATION ERRORS

AWARENESS OF DENTISTS ABOUT MEDICATION ERRORS AWARENESS OF DENTISTS ABOUT MEDICATION ERRORS Sangeetha P 1, Prabhawati P I 2, Inamadar P I 3, HOW TO CITE THIS ARTICLE: Sangeetha P, Prabhawati PI, Inamadar PI,. Awareness of dentists about medication

More information

MEDICATION PRESCRIBING ERRORS IN PAEDIATRIC OUTPATIENTS PRESCRIPTIONS AT A PAEDIATRIC HOSPITAL IN NEPAL

MEDICATION PRESCRIBING ERRORS IN PAEDIATRIC OUTPATIENTS PRESCRIPTIONS AT A PAEDIATRIC HOSPITAL IN NEPAL WORLD JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES Sunil et al. SJIF Impact Factor 6.041 Volume 6, Issue 1, 1004-1013 Research Article ISSN 2278 4357 MEDICATION PRESCRIBING ERRORS IN PAEDIATRIC OUTPATIENTS

More information

Navigating Pain Management during the Opioid Epidemic: Focus Group Findings

Navigating Pain Management during the Opioid Epidemic: Focus Group Findings Navigating Pain Management during the Opioid Epidemic: Focus Group Findings David Cameron Oregon Health & Science University Department of Family Medicine, Portland, OR Funding received from AHRQ (5R18HS024227-02)

More information

Failure Modes Effects Analysis of Morphine Prescribing

Failure Modes Effects Analysis of Morphine Prescribing Failure Modes Effects Analysis of Morphine Prescribing Hilary Writer MD FRCPC Elaine Wong BScPhm CPSI Patient Safety and Quality Improvement Forum,14 April 2010 Outline Rationale Medication Incidents with

More information

CURT J. CARLSON, M.D., Pharm.D.

CURT J. CARLSON, M.D., Pharm.D. CURT J. CARLSON, M.D., Pharm.D. Contact Information: curt_carlson@pba.edu EDUCATION 2001 2005 School of Pharmacy Doctor of Pharmacy Magna Cum Laude 1995 1997 Family Practice Residency Fairfax Family Practice

More information

HEALTH LITERACY. Michael Wolf, MA MPH PhD

HEALTH LITERACY. Michael Wolf, MA MPH PhD HEALTH LITERACY A Matter of Healthcare Quality & Equity Michael Wolf, MA MPH PhD Health Literacy and Learning Program Feinberg School of Medicine School of Education & Social Policy Northwestern University

More information

Delayed or missed follow-up of laboratory tests is

Delayed or missed follow-up of laboratory tests is Reports from the field Follow-up of Abnormal Metanephrine and Catecholamine Testing: Chasing Missed Neuroendocrine Tumors Richard Zamore, MD, MPH, Beth Harubin, MS, Megan Sweeney, BS, and Saul N. Weingart,

More information

Falls Risk Screening, Assessment, and Referral

Falls Risk Screening, Assessment, and Referral Falls Risk Screening, Assessment, and Referral Kady Reese, MPH, CPHQ Lana Comstock, MSN, RN Iowa Fall Symposium July 13, 2017 Goals Identify risk assessment tools for varied patient populations Recite

More information

Mass General s Substance Use Disorder Initiative

Mass General s Substance Use Disorder Initiative Mass General s Substance Use Disorder Initiative Martha Kane, PhD Sarah Wakeman, MD, FASAM Clinical and Medical Directors, Mass General Hospital Substance Use Disorder Initiative None Disclosures Objectives

More information

Pharmacy 445 Public Health Applications in Pharmacy Jacqueline Gardner, Ph.D. Professor, Department of Pharmacy. Pharmacists Role 1

Pharmacy 445 Public Health Applications in Pharmacy Jacqueline Gardner, Ph.D. Professor, Department of Pharmacy. Pharmacists Role 1 Pharmacy 445 Public Health Applications in Pharmacy Jacqueline Gardner, Ph.D. Professor, Department of Pharmacy Pharmacists Role 1 Promotion of health improvement, wellness, and disease prevention in cooperation

More information

Public Health Applications in Pharmacy

Public Health Applications in Pharmacy 1 Pharmacy 445 Public Health Applications in Pharmacy Jacqueline Gardner, Ph.D. Professor, Department of Pharmacy 2 Public or Community Health Distinct from clinical medicine, which focuses upon an individual

More information

Improving Opioid Agonist Therapies with System Change

Improving Opioid Agonist Therapies with System Change Improving Opioid Agonist Therapies with System Change DENNIS MCCARTY OHSU- PSU SCHOOL OF PUBLIC HEALTH OREGON HEALTH & SCIENCE UNIVERSITY PORTLAND, OR 97239 BOOST LAUNCH VANCOUVER, BC SEPTEMBER 15, 2017

More information

High Alert Medications: Reducing Patient Harm. Tennessee Center for Patient Safety Regional Meetings 2017 Brian D. Esters, PharmD, CPPS

High Alert Medications: Reducing Patient Harm. Tennessee Center for Patient Safety Regional Meetings 2017 Brian D. Esters, PharmD, CPPS High Alert Medications: Reducing Patient Harm Tennessee Center for Patient Safety Regional Meetings 2017 Brian D. Esters, PharmD, CPPS Learning Objectives Define High-Alert Medications Identify potential

More information

Drug Utilization Review & Cost Reduction Strategies. Esther Liu, PharmD, MSIA, CGP Clinical Pharmacist Outcome Resources

Drug Utilization Review & Cost Reduction Strategies. Esther Liu, PharmD, MSIA, CGP Clinical Pharmacist Outcome Resources Drug Utilization Review & Cost Reduction Strategies Esther Liu, PharmD, MSIA, CGP Clinical Pharmacist Outcome Resources Goals and Objectives Define Drug Utilization Reviews Interpret various performance

More information

3/27/2019. Reducing Inpatient Opioid Consumption. Conflict of Interest. Educational Objectives

3/27/2019. Reducing Inpatient Opioid Consumption. Conflict of Interest. Educational Objectives Reducing Inpatient Opioid Consumption Creating a Therapeutic Foundation with Breakthrough Analgesia Based on Patient Function Chad Dieterichs, MD Peggy Lutz, FNP-BC, RN-BC March 27, 2019 1 Conflict of

More information